273 related articles for article (PubMed ID: 12407934)
21. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective.
Dencker SJ
J Clin Psychiatry; 1984 May; 45(5 Pt 2):22-7. PubMed ID: 6143744
[TBL] [Abstract][Full Text] [Related]
22. Strategies for dosing and switching antipsychotics for optimal clinical management.
Buckley PF; Correll CU
J Clin Psychiatry; 2008; 69 Suppl 1():4-17. PubMed ID: 18484804
[TBL] [Abstract][Full Text] [Related]
23. [Which collateral effects influence in the adherence with antipsychotic medication?].
Lamela CA
Vertex; 2002; 13 Suppl 1():31-9. PubMed ID: 12122426
[TBL] [Abstract][Full Text] [Related]
24. The long term--maximising potential for rehabilitation in patients with schizophrenia.
Fagiolini A; Goracci A
Eur Neuropsychopharmacol; 2007 Mar; 17 Suppl 2():S123-9. PubMed ID: 17336767
[TBL] [Abstract][Full Text] [Related]
25. Choosing an atypical antipsychotic.
Sussman N
Int Clin Psychopharmacol; 2002 Aug; 17 Suppl 3():S29-33. PubMed ID: 12570069
[TBL] [Abstract][Full Text] [Related]
26. The efficacy of piquindone, a new atypical neuroleptic, in the treatment of the positive and negative symptoms of schizophrenia.
Cohen JD; Van Putten T; Marder S; Berger PA; Stahl SM
J Clin Psychopharmacol; 1987 Oct; 7(5):324-9. PubMed ID: 2890671
[TBL] [Abstract][Full Text] [Related]
27. [Extrapyramidal effects of antipsychotic drugs].
Kulisevsky J; Otermin P
Neurologia; 2003 Jun; 18(5):262-8. PubMed ID: 12768512
[TBL] [Abstract][Full Text] [Related]
28. Differential effects of a new dibenzo-epine neuroleptic compared with haloperidol. Results of an open and crossover study.
Mann K; Bartels M; Gärtner HJ; Schied HW; Wagner W; Heimann H
Pharmacopsychiatry; 1987 Jul; 20(4):155-9. PubMed ID: 2886997
[TBL] [Abstract][Full Text] [Related]
29. Recognition and management of acute neuroleptic-induced extrapyramidal motor and mental syndromes.
Dose M
Pharmacopsychiatry; 2000 Sep; 33 Suppl 1():3-13. PubMed ID: 11072761
[TBL] [Abstract][Full Text] [Related]
30. Effects of second generation antipsychotics on leptin and ghrelin.
Esen-Danaci A; Sarandöl A; Taneli F; Yurtsever F; Ozlen N
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1434-8. PubMed ID: 18579280
[TBL] [Abstract][Full Text] [Related]
31. [Therapeutic alliance, a stake in schizophrenia].
Charpentier A; Goudemand M; Thomas P
Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
[TBL] [Abstract][Full Text] [Related]
32. Patients in the early phases of schizophrenia and schizoaffective disorders effectively treated with risperidone long-acting injectable.
Parellada E; Andrezina R; Milanova V; Glue P; Masiak M; Turner MS; Medori R; Gaebel W
J Psychopharmacol; 2005 Sep; 19(5 Suppl):5-14. PubMed ID: 16144781
[TBL] [Abstract][Full Text] [Related]
33. [Testing basic visual functions in the evaluation of extrapyramidal side effects of antipsychotic agents].
Kéri S; Antal A; Szekeres G; Szendi I; Kovács Z; Janka Z; Benedek G
Orv Hetil; 1998 Feb; 139(5):235-8. PubMed ID: 9489377
[TBL] [Abstract][Full Text] [Related]
34. [Three-dimensional ultrasonic movement analysis of gait and hand-movements in schizophrenic patients].
Putzhammer A; Perfahl M; Pfeiff L; Müller JL
Psychiatr Prax; 2005 Apr; 32 Suppl 1():S38-42. PubMed ID: 15818519
[TBL] [Abstract][Full Text] [Related]
35. Discontinuing and switching antipsychotic medications: understanding the CATIE schizophrenia trial.
Weiden PJ
J Clin Psychiatry; 2007; 68 Suppl 1():12-9. PubMed ID: 17286523
[TBL] [Abstract][Full Text] [Related]
36. Depot neuroleptics: a comparative review of standard, intermediate, and low-dose regimens.
Kane JM; Woerner M; Sarantakos S
J Clin Psychiatry; 1986 May; 47 Suppl():30-3. PubMed ID: 2871014
[TBL] [Abstract][Full Text] [Related]
37. [Body weight increase: a side effect of zotepin (Nipolept)?].
Wetterling T; Müssigbrodt H
Nervenarzt; 1996 Mar; 67(3):256-61. PubMed ID: 8901286
[TBL] [Abstract][Full Text] [Related]
38. An overview of side effects caused by typical antipsychotics.
Arana GW
J Clin Psychiatry; 2000; 61 Suppl 8():5-11; discussion 12-3. PubMed ID: 10811237
[TBL] [Abstract][Full Text] [Related]
39. Clozapine maintenance therapy in schizophrenia.
Gaszner P; Makkos Z
Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
[TBL] [Abstract][Full Text] [Related]
40. Extrapyramidal side effects: a historical perspective.
Rifkin A
J Clin Psychiatry; 1987 Sep; 48 Suppl():3-6. PubMed ID: 2887555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]